Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma

Detalles Bibliográficos
Autores principales: Abuelgasim, Khadega A., Alzahrani, Mohsen, Alsharhan, Yousef, Khairi, Moataz, Hommady, Mohammed, Gmati, Giamal, Salama, Hind, Ali, Osama, Alahmari, Bader, Masuadi, Emad M., Alaskar, Ahmed, Alhejazi, Ayman, Damlaj, Moussab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760548/
https://www.ncbi.nlm.nih.gov/pubmed/30700792
http://dx.doi.org/10.1038/s41409-019-0454-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760548/
https://www.ncbi.nlm.nih.gov/pubmed/30700792
http://dx.doi.org/10.1038/s41409-019-0454-z

Ejemplares similares